09.12.2012 Views

Table of Contents - WOC 2012

Table of Contents - WOC 2012

Table of Contents - WOC 2012

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

IS-TEC-SU 311 (6)<br />

New Developments in OCT<br />

Schmetterer Leopold<br />

Optical coherence tomography has become a standard tool in imaging the<br />

retina, the optic nerve head and the anterior segment <strong>of</strong> the eye. The<br />

introduction <strong>of</strong> Fourier Domain systems over Time Domain systems has brought<br />

improvements in acquisition speed as well as in resolution. The present talk<br />

discusses new approaches including ultra-high speed OCT systems, systems<br />

using ultra-broadband light sources, use <strong>of</strong> wavelengths in the near infrared<br />

and assessment <strong>of</strong> functional data.<br />

IS-TEC-SU 311 (7)<br />

Advances in the Treatment <strong>of</strong> Diabetic Retinopathy<br />

El-Asrar Ahmed Abu (1)<br />

1. King Saud University<br />

Strict metabolic control, tight blood pressure control, laser photocoagulation<br />

and vitrectomy remain the standard care for diabetic retinopathy. Focal/grid<br />

photocoagulation is a better treatment than intravitreal triamcinolone acetonide<br />

in eyes with diabetic macular edema. Anti-vascular endothelial growth factor<br />

agents result in temporary improvement <strong>of</strong> visual acuity and short-term<br />

reduction <strong>of</strong> central macular thickness in patients with refractory diabetic<br />

macular edema and effective adjunctive treatment to laser photocoagulation.<br />

Vitrectomy with removal <strong>of</strong> posterior hyaloid seems effective in eyes with<br />

persistent diffuse diabetic macular edema, particularly in eyes with associated<br />

vitreomacular traction.<br />

Main Causes <strong>of</strong> Irreversible Blindness: Diabetic Retinopathy and<br />

Glaucoma - Diagnostic and Therapeutic Challenges<br />

Sun 19 Feb 13:30 - 15:00 Conference Room A4<br />

IS-EPI-SU 312 (1)<br />

Diabetes Retinopathy Screening - The Kenya Experience<br />

Kibata Amos<br />

A screening program for diabetic retinopathy was initiated in central Kenya a<br />

year ago by Upper Hill Eye and Laser Centre (UHEAL), a private eye clinic in<br />

Nairobi, Kenya. To date close to 3000 diabetics patients have had a dilated<br />

eye examination with over 200 laser procedures performed using a state <strong>of</strong><br />

the art mobile laser unit. The challenges faced in setting up the program will<br />

be discussed. In addition a summary <strong>of</strong> the ocular and systemic findings from<br />

this program will be made. Finally, experiences learnt in the past year will be<br />

outlined.<br />

IS-EPI-SU 312 (2)<br />

New Drugs in the Treatment <strong>of</strong> the Diabetic Retinopathy<br />

Lazic Ratimir (1)<br />

1. Eye Clinic Svjetlost<br />

Until recently laser photocoagulation was mainly used in the treatment <strong>of</strong> DR<br />

to control neovascularization (NV) and diabetic macular edema (DME). If<br />

the disease progressed to proliferative stage, pars plana vitrectomy was<br />

required. However in the new anti-VEGF era, anti-VEGF drugs have become<br />

increasingly used in treatment <strong>of</strong> DME, as adjunct therapy to laser for NV and<br />

vitreal haemorrhage and to facilitate pending vitrectomy. Also new sustain<br />

release dexamethasone implant has shown to be effective in prolonged control<br />

<strong>of</strong> DME.<br />

IS-EPI-SU 312 (3)<br />

Minimally Invasive Vitrectomy in Diabetic Retinopathy Treatment<br />

Tomic Zoran (1)<br />

1. University Eye Clinic Svjetlost<br />

Pars plana vitrectomy has mainly been used in treatment <strong>of</strong> advance<br />

proliferative diabetic retinopathy (P DR) cases. However with the development<br />

<strong>of</strong> new minimally invasive approach using 25 and 23 gauge instruments,<br />

early vitrectomy has shown to be very effective in early control <strong>of</strong> disease<br />

progression and in achieving good functional results. Anti-VEGF treatment<br />

prior to vitrectomy has facilitated the membrane peeling and <strong>of</strong>fered better<br />

control <strong>of</strong> intraoperative hemorrhage. The author will show a video <strong>of</strong> selected<br />

cases.<br />

IS-EPI-SU 312 (4)<br />

Glaucoma after Silicone Oil Tamponade<br />

Kuljaca Zoran (1)<br />

<strong>WOC</strong><strong>2012</strong> Abstract Book<br />

1. Milos Eye Hospital<br />

The use <strong>of</strong> silicone oil, when managing retinal detachments, could be<br />

encountered with chronic elevation <strong>of</strong> intraocular pressure. Risk factors<br />

to developing include preexisting glaucoma, aphakia, oil in the anterior<br />

chamber, early postoperative pressure spikes, diabetes, trauma and iris<br />

neovasularisation. Inferior peripheral iridotomy during the surgery reduced<br />

the incidence <strong>of</strong> acute angle closure glaucoma. Removal <strong>of</strong> the silicone oil<br />

may not resolve the problem and aqueous suppressants should be prescribed.<br />

Glaucoma drainage surgery should be preferably performed simultaneously<br />

with the oil removal, also combined with optional AntiVEGF therapy or<br />

cycloablative procedure.<br />

IS-EPI-SU 312 (5)<br />

Practical Approaches to the Management <strong>of</strong> Glaucoma<br />

Damji Karim (1)<br />

1. University <strong>of</strong> Alberta<br />

A practical framework for approaching glaucoma management will be<br />

presented:<br />

• Establish a good baseline (diagnosis, structure and function) and categorize<br />

the risk <strong>of</strong> progression<br />

• Set therapeutic goal (s)<br />

• Stage eye (s) and set target IOP range<br />

• Decide with the patient whether to treat or not<br />

• Individualize treatment utilizing the best available science (evidence) as well<br />

as art (patient empowerment and ‘biopsychosociospiritual’ perspective).<br />

IS-EPI-SU 312 (6)<br />

Establishing a Diabetic Retinopathy Screening Service in Sub<br />

Saharan Africa: The Kilimanjaro Region Experience<br />

Hall Anthony (1)<br />

1. Newcastle Eye Hospital<br />

The Kilimanjaro Diabetic programme was started in response to an increasing<br />

burden <strong>of</strong> diabetic patients blinded by untreated retinopathy. The programme<br />

sought to introduce a camera based screening programme for retinopathy<br />

through a comprehensive approach <strong>of</strong> educating health care workers and<br />

patients about diabetes complications. District hospitals were encouraged to<br />

start diabetic clinics. A regional register <strong>of</strong> known diabetic patients was created.<br />

Photographers and graders were trained. 2673 patients have been registered.<br />

3.8% have proliferative retinopathy and 15.2% treatable maculopathy.<br />

IS-EPI-SU 312 (7)<br />

RAAB+ Dr Surveys in Assessing the Prevalence <strong>of</strong> Blindness from<br />

Diabetic Retinopathy<br />

Yorston David (1)<br />

1. Tennent Institute <strong>of</strong> Ophthalmology<br />

RABID surveys are a relatively inexpensive method for assessing the<br />

prevalence <strong>of</strong> diabetes, diabetic retinopathy, and blindness, as well as the<br />

major avoidable causes <strong>of</strong> visual impairment. Recently completed surveys in<br />

Latin America, Africa and the Middle East show a high prevalence <strong>of</strong> diabetic<br />

retinopathy in people over 50 years old. Only a small proportion <strong>of</strong> those who<br />

need treatment have evidence <strong>of</strong> previous laser. The survey methodology will<br />

be described and the results <strong>of</strong> the surveys will be presented.<br />

IS-EPI-SU 312 (8)<br />

Glaucoma and the Anterior Segment (Siagnosis and Treatment)<br />

Nagy Zoltan (1)<br />

1. Department <strong>of</strong> Ophthalmology, Semmelweis University<br />

Undiagnosed glaucoma might be a limiting factor in achieving good visual<br />

function following ophthalmic surgeries. The importance <strong>of</strong> pachymetry, visual<br />

field testing, papillary morphology, topography and other modern testing will<br />

be discussed. At the end <strong>of</strong> the session participants should be able to identify,<br />

diagnose and treat early glaucoma cases in order to achieve the best visual<br />

results during their patient management.<br />

297

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!